Global E-Pharma Market is expected to reach USD
109.2 billion by 2025, according to
a new report by Grand View Research, Inc. The market is primarily driven by
constant increase in the number of internet users, improved access to web-based
& online services, and rapid increase in aging population who find it
difficult to visit pharmacies. Convenience, affordability, and ease in
availability of medicines are fueling market growth.
Increase
in prevalence of chronic conditions and diseases across the globe is resulting
in constant growth in demand for various d rugs and healthcare products. High
cost of treatment is indicating the need to reduce health care cost. Online
pharmacies are gaining popularity owing to lucrative offers such as price
discounts that result in cost savings. In addition, increase in adoption of
e-prescriptions in hospitals and other healthcare facilities is further
expected to boost growth.
High-unmet
needs of emerging economies is one of the key driving factors. Government
initiatives, increase in investments, changing regulations, and increasing
penetration of internet and broadband in urban as well as rural areas are
contributing to the growth of the market. Many new players are entering the
market as the healthcare sector is offering huge potential to the online health
retailers due to the ever-growing demand for healthcare products and services.
However,
growth in illegal online pharmacies is restraining the growth. These
illegitimate websites may offer counterfeit and unapproved drugs, which make
people skeptical about purchasing medicines online.
Full Research Report on Global E-Pharma
Market Analysis:
http://www.grandviewresearch.com/industry-analysis/e-pharma-market
http://www.grandviewresearch.com/industry-analysis/e-pharma-market
Further Key Findings From the Report
Suggest:
- North America held majority
of the share in 2016 due to increase in online purchases, growing elderly
population, and high adoption of IT in healthcare
- The U.S. is the largest
market in North America owing to the presence of various key players and a
large tech-savvy population
- Asia Pacific is expected to
be the fastest growing segment due to the presence of emerging economies
like China & India and improving infrastructure
- Some of the key players are
The Kroger Co., Walgreen Co.; Wal-Mart Stores, Inc.; CVS Health; Express
Scripts Holding Company; Giant Eagle, Inc.; DocMorris (Zur Rose Group);
Rowlands Pharmacy; and OptumRx, Inc.
View more reports of this category by
Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the Global
E-Pharma Market on the basis of region:
e-Pharma Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
View Press Release of this research
report by Grand View Research: http://www.grandviewresearch.com/press-release/global-e-pharma-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment